N-acetylcysteine may reduce repetitive behaviors in children with autism: a case series

References

• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
   Google Scholar
• Ospina MB, Krebs Seida J, Clark B, et al. Behavioural and developmental interventions for autism spectrum disorder: a clinical systematic review. PLoS ONE. 2008;3(11):e3755. doi: 10.1371/journal.pone.0003755
   PubMed Web of Science ®Google Scholar
• Pandina GJ, Bossie CA, Youssef E, et al. Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trial. J Autism Dev Disord. 2007;37(2):367–373. doi: 10.1007/s10803-006-0234-7
   PubMed Web of Science ®Google Scholar
• Coskun M, Karakoc S, Kircelli F, et al. Effectiveness of mirtazapine in the treatment of inappropriate sexual behaviors in individuals with autistic disorder. J Child Adolesc Psychopharmacol. 2009;19:203–206. doi: 10.1089/cap.2008.020
   PubMed Web of Science ®Google Scholar
• Marcus RN, Owen R, Kamen L, et al. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry. 2009;48(11):1110–1119. doi: 10.1097/CHI.0b013e3181b76658
   PubMed Web of Science ®Google Scholar
• Aman M, Rettiganti M, Nagaraja HN, et al. Tolerability, safety, and benefits of risperidone in children and adolescents with autism: 21-month follow-up after 8-week placebo-controlled trial. J Child Adolesc Psychopharmacol. 2015;25(6):482–493. doi: 10.1089/cap.2015.0005
   PubMed Web of Science ®Google Scholar
• Arnold LE, Aman MG, Cook AM, et al. Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial. J Am Acad Child Adolesc Psychiatry. 2006;45(10):1196–1205. doi: 10.1097/01.chi.0000231976.28719.2a
   PubMed Web of Science ®Google Scholar
• Posey DJ, Aman MG, McCracken JT, et al. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures. Biol Psychiatry. 2007;61(4): 538–544. doi: 10.1016/j.biopsych.2006.09.028
   PubMed Web of Science ®Google Scholar
• Ghanizadeh A, Moghimi-Sarani E. A randomized double blind placebo controlled clinical trial of N-acetylcysteine added to risperidone for treating autistic disorders. BMC Psychiatry. 2013;13(196):1–7.
   Google Scholar
• Accordino RE, Kidd C, Politte LC, et al. Psychopharmacological interventions in autism spectrum disorder. Expert Opin Pharmacother. 2016;17(7):937–952. doi: 10.1517/14656566.2016.1154536
   PubMed Web of Science ®Google Scholar
• Anderson GM, Scahill L, McCracken JT, et al. Effects of short- and long-term risperidone treatment on prolactin levels in children with autism. Biol Psychiatry. 2007;61(4):545–550. doi: 10.1016/j.biopsych.2006.02.032
   PubMed Web of Science ®Google Scholar
• Memik NÇ, Gündoğdu ÖY, Tural Ü. Use of N-acetylcysteine in obsessive-compulsive and related disorders. Bull Clin Psychopharmacol. 2015;25:193–206. doi: 10.5455/bcp.20140811064455
   Google Scholar
• Lafleur DL, Pittenger C, Kelmendi B, et al. N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive compulsive disorder. Psychopharmacology. 2006;184:254–256. doi: 10.1007/s00213-005-0246-6
   PubMed Web of Science ®Google Scholar
• Grant JE, Odlaug BL, Kim SW. N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double blind, placebo-controlled study. Arch Gen Psychiatry. 2009;66(7):756–763. doi: 10.1001/archgenpsychiatry.2009.60
   PubMed Web of Science ®Google Scholar
• Dean O, Giorlando F, Berk M. N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action. J Psychiatry Neurosci. 2011;36(2):78–86. doi: 10.1503/jpn.100057
   PubMed Web of Science ®Google Scholar
• Wink LK, Adams R, Wang Z, et al. A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder. Mol Autism. 2016;21(7):26. doi:10.1186/s13229-016-0088-6
   Web of Science ®Google Scholar
• Hardan AY, Fung LK, Libove RA, et al. A randomized controlled pilot trial of oral N-acetylcysteine in children with autism. Biol Psychiatry. 2012;71(11):956–961. doi: 10.1016/j.biopsych.2012.01.014
   PubMed Web of Science ®Google Scholar
• Nikoo M, Radnia H, Farokhnia M, et al. N-acetylcysteine as an adjunctive therapy to risperidone for treatment of irritability in autism: a randomized, double-blind, placebo-controlled clinical trial of efficacy and safety. Clin Neuropharmacol. 2015;38(1):11–17. doi: 10.1097/WNF.0000000000000063
   PubMed Web of Science ®Google Scholar
• Schopler E, Reichler R, Rochen Renner B. The childhood autism rating scale. Western Psychological Services; 1988.
   Google Scholar
• Aman MG, Singh NN, Stewart AW, et al. The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. Am J Ment Defic. 1985;89(5):485–491.
   PubMedGoogle Scholar
• Marler S, Sanders KB, Veenstra-VanderWeele J. N-acetylcysteine as treatment for self-injurious behavior in a child with autism. J Child Adolesc Psychopharmacol. 2014;24(4):231–234. doi: 10.1089/cap.2013.0137
   Web of Science ®Google Scholar
• Deepmala, SJ, Kumar N, Delhey L, et al. Clinical trials of N-acetylcysteine in psychiatry and neurology: a systematic review. Neurosci Biobehav Rev. 2015;55:294–321. doi: 10.1016/j.neubiorev.2015.04.015
   PubMed Web of Science ®Google Scholar
• Afshar H, Roohafza H, Mohammad-Beigi H, et al. N-acetylcysteine add-on treatment in refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial. J Clin Psychopharmacol. 2012;32(6):797–803. doi: 10.1097/JCP.0b013e318272677d
   PubMed Web of Science ®Google Scholar
• Bloch MH, Panza KE, Grant JE, et al. N-Acetylcysteine in the treatment of pediatric trichotillomania: a randomized, double-blind, placebo-controlled add-on trial. J Am Acad Child Adolesc Psychiatry. 2013;52(3):231–240. doi: 10.1016/j.jaac.2012.12.020
   PubMed Web of Science ®Google Scholar
• Bloch MH, Panza KE, Yaffa A, et al. N-Acetylcysteine in the treatment of pediatric tourette syndrome: randomized, double-blind, placebo-controlled add-on trial. J Child Adolesc Psychopharmacol. 2016;26(4):327–334. doi: 10.1089/cap.2015.0109
   Web of Science ®Google Scholar